1-13 of 13
Lyndsay N. Harris
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT160: BVD-523FB (Ulixertinib) in Patients with Tumors with BRAF Fusions, or with Non-V600E, Non-V600K BRAF Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Sub-protocol EAY131-Z1L

Vivek Subbiah, Fengmin Fengmin, Ragini Kudchadkar, Ryan J. Sullivan, Edith P. Mitchell, John J. Wright, Helen X. Chen, Robert J. Gray, Xin Victoria Wang, Lisa M. McShane, Larry V. Rubinstein, David Patton, P. Mickey Williams, Tilak K. Sundaresan, Barbara A. Conley, Carlos L. Arteaga, Lyndsay N. Harris, Peter J. O'Dwyer, Alice P. Chen, Keith T. Flaherty
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT160.
DOI: https://doi.org/10.1158/1538-7445.AM2022-CT160
Published: 15 June 2022
View article
Journal Articles

Abstract LB-010: Molecular analysis for therapy choice (NCI-MATCH, EAY131) arm Z1B: Phase II trial of palbociclib for CCND1, 2 or 3 amplified tumors

Amy S. Clark, Fangxin Hong, Richard S. Finn, Angela M. DeMichele, Edith P. Mitchell, James Zweibel, Fernanda I. Arnaldez, Lisa M. McShane, Shuli Li, Robert J. Gray, Larry V. Rubenstein, David Patton, P Mickey Williams, Stanley R. Hamilton, Mehmet S. Copur, Sameer S. Kasbari, Ravneet Thind, Barbara A. Conley, Peter J. O'Dwyer, Lyndsay N. Harris, Carlos L. Arteaga, Alice P. Chen, Keith T. Flaherty
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): LB-010.
DOI: https://doi.org/10.1158/1538-7445.AM2019-LB-010
Published: 01 July 2019
View article
Journal Articles

Abstract CT139: NCI Molecular Analysis for Therapy Choice (NCI-MATCH EAY131) arm B: Phase II study of afatinib in patients (pts) with HER2 (ERBB2) activating mutations

Philippe L. Bedard, Shuli Li, Kari B. Wisinski, Eddy S. Yang, Sewanti A. Limaye, Edith P. Mitchell, James A. Zwiebel, Jeffrey Moscow, Robert J. Gray, Lisa M. McShane, Larry V. Rubenstein, David R. Patton, P Mickey Williams, Stanley R. Hamilton, Barbara A. Conley, Carlos L. Arteaga, Lyndsay N. Harris, Peter J. O'Dwyer, Alice P. Chen, Keith T. Flaherty
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): CT139.
DOI: https://doi.org/10.1158/1538-7445.AM2019-CT139
Published: 01 July 2019
View article
Journal Articles

Abstract CT138: NCI-MATCH EAY131 -Z1I: Phase II study of AZD1775, a wee-1 kinase inhibitor, in patients with tumors containing BRCA1 and BRCA2 mutations

Shivaani Kummar, Shuli Li, Kim Reiss, James M. Ford, Edith P. Mitchell, James A. Zwiebel, Naoko Takebe, Robert J. Gray, Lisa M. McShane, Larry V. Rubinstein, David Patton, Paul Mickey Williams, Stanley R. Hamilton, Adam Brufsky, Barbara A. Conley, Carlos L. Arteaga, Lyndsay N. Harris, Peter J. O'Dwyer, Alice P. Chen, Keith T. Flaherty
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): CT138.
DOI: https://doi.org/10.1158/1538-7445.AM2019-CT138
Published: 01 July 2019
View article
Journal Articles

Abstract 304: HER2 basal tumors have frequent mutation of HER3 and are more resistant to HER2-targeted therapy

Vinay Varadan, Salendra Singh, Hannah Gilmore, Shikha Parsai, George Somlo, Maysa Abu-Khalaf, William Sikov, Lyndsay N. Harris
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 304.
DOI: https://doi.org/10.1158/1538-7445.AM2016-304
Published: 15 July 2016
View article
Journal Articles

Abstract 2836: A discovery and validation set of breast cancer preoperative clinical trials show an increase in immune score upon brief-exposure to trastuzumab (T) and the HER2-enriched subtype predict response to combination chemotherapy and T

Vinay Varadan, Kristy L.S. Miskimen, Shikha Parsai, Ian E. Krop, Eric P. Winer, Veerle Bossuyt, Maysa Abu-Khalaf, William Sikov, Lyndsay N. Harris
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 2836.
DOI: https://doi.org/10.1158/1538-7445.AM2015-2836
Published: 01 August 2015
View article
Journal Articles

Abstract P4-01-01: Circulating tumor cell (CTC) enumeration and HER2 assessment as predictors of breast cancer outcomes in the ALTTO (BIG 2-06, Alliance N063D) Trial

Minetta C Liu, Brigitte Rack, Amylou C Dueck, David W Hillman, Michael B Campion, Monica M Reinholz, Kevin C Halling, Christos Sotiriou, Françoise Rothé, Marion Maetens, Ghizlane Rouas, Wolfgang Janni, Antonio C Wolff, Lyndsay N Harris, Julie R Gralow, Kathleen I Pritchard, Susan Ellard, Nguyet A Le-Lindqwister, Frances Boyle, Evandro De Azambuja, Martine J Piccart-Gebhart, Michail Ignatiadis, Edith A Perez
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P4-01-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS14-P4-01-01
Published: 01 May 2015
View article
Journal Articles

Abstract PD6-5: Profiling of ESR1-mutated metastatic breast cancers by FoundationOne® allows a broad genomic understanding for potential clinical implications

Norma A Palma, Siraj Ali, Garrett Frampton, Kai Wang, Hannah Gilmore, Julio Peguero, Lyndsay N Harris, Massimo Cristofanilli, Juliann Chmielecki, Jeffrey S Ross, Deborah Morosini, Vincent A Miller, Phil J Stephens, Gary Palmer, Joyce O'Shaughnessy
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): PD6-5.
DOI: https://doi.org/10.1158/1538-7445.SABCS14-PD6-5
Published: 01 May 2015
View article
Journal Articles

Abstract 1828: RNA-seq reveals association of pCR and changes in lncRNA expression in pre-operative bevacizumab treatment of breast cancer.

Nilanjana Banerjee, Vinay Varadan, Sitharthan Kamalakaran, Angel Janevski, Kristy Miskimen, Nicole Williams, Maysa Abu-Khalaf, William Sikov, Lyndsay N. Harris, Nevenka Dimitrova
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 1828.
DOI: https://doi.org/10.1158/1538-7445.AM2013-1828
Published: 15 April 2013
View article
Journal Articles

Abstract 705: HER2 assessment to define outcomes for breast cancer patients treated with neoadjuvant therapy

Huan Cheng, Yalai Bai, Willliam Sikov, Natalie Sinclair, Maysa Abu-Khalaf, Lyndsay N. Harris, David L. Rimm
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 705.
DOI: https://doi.org/10.1158/1538-7445.AM2012-705
Published: 15 April 2012
View article
Journal Articles

Abstract 4719: Dynamic changes in gene expression after one dose of trastuzumab (T) reveal novel biomarkers of response to combination therapy in HER2 positive early stage breast cancer

Lyndsay N. Harris, Emmett Sprecher, Lisa Wei-Gu, Kimberly Lezon-Geyda, Sudipa Sakar, Ian Krop, Eric P. Winer, David P. Tuck
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 4719.
DOI: https://doi.org/10.1158/1538-7445.AM2011-4719
Published: 15 April 2011
View article
Journal Articles

Trastuzumab-Induced HER Reprogramming in “Resistant” Breast Carcinoma Cells

Murli Narayan, Jason A. Wilken, Lyndsay N. Harris, Andre T. Baron, Kimberly D. Kimbler, Nita J. Maihle
Journal: Cancer Research
Cancer Res (2009) 69 (6): 2191–2194.
DOI: https://doi.org/10.1158/0008-5472.CAN-08-1056
Published: 17 March 2009
View article
PDF
Journal Articles

Validating predictive profiles in HER2 positive early stage breast cancer using RNA microarray

Fanglei You, Scott Carter, Aron Eklund, J. D. Iglehart, Dennis Sgroi, Andrea Richardson, Zoltan Szallasi, Lyndsay N. Harris
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 442–443.
Published: 01 May 2005
View article